Quétiapine And NotChristoph M. Kosinski
List of bibliographic references
Number of relevant bibliographic references: 14.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000619 | Richard A. Walsh [Canada] ; Anthony E. Lang [Canada] | Early-Onset Tardive Dyskinesia in a Neuroleptic-Naive Patient Exposed to Low-Dose Quetiapine |
| 000856 | Mohammed T. Ahmad [Singapour] ; Kumar M. Prakash [Singapour] | Reversible Hyperkinetic Movement Disorder Associated with Quetiapine Withdrawal |
| 001695 | Jose M. Rabey [Israël] ; Tatiana Prokhorov ; Ala Miniovitz ; Eugenia Dobronevsky ; Colin Klein | Effect of quetiapine in psychotic parkinson's disease patients : A double-blind labeled study of 3 months' duration |
| 001D26 | Costas Michaelides [États-Unis] ; Manisha Thakore-James [États-Unis] ; Raymon Durso [États-Unis] | Reversible withdrawal dyskinesia associated with quetiapine |
| 001D33 | Hubert H. Fernandez [États-Unis] ; Martha E. Trieschmann [États-Unis] ; Michael S. Okun [États-Unis] | Rebound psychosis: Effect of discontinuation of antipsychotics in Parkinson's disease |
| 001E73 | William G. Ondo [États-Unis] ; Ron Tintner [États-Unis] ; Kevin Dat Voung [États-Unis] ; DEJIAN LAI [États-Unis] ; George Ringholz [États-Unis] | Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease |
| 002030 | Jorge L. Juncos [États-Unis] ; Vicki J. Roberts [États-Unis] ; Marian L. Evatt [États-Unis] ; Rita D. Jewart [États-Unis] ; Colleen D. Wood [États-Unis] ; Larry S. Potter [États-Unis] ; Hann-Chang Jou [États-Unis] ; Paul P. Yeung [États-Unis] | Quetiapine improves psychotic symptoms and cognition in Parkinson's disease |
| 002289 | Roy R. Reeves [États-Unis] ; Vincent Liberto [États-Unis] | Treatment of essential blepharospasm with quetiapine |
| 002414 | Hubert H. Fernandez [États-Unis] ; Martha E. Trieschmann [États-Unis] ; Monica A. Burke [États-Unis] ; Carol Jacques [États-Unis] ; Joseph H. Friedman [États-Unis] | Long-term outcome of quetiapine use for psychosis among parkinsonian patients |
| 002584 | Sujana Reddy [États-Unis] ; Stewart A. Factor [États-Unis] ; Eric S. Molho [États-Unis] ; Paul J. Feustel [États-Unis] | The effect of quetiapine on psychosis and motor function in Parkinsonian patients with and without dementia |
| 002789 | Drugs to treat dementia and psychosis | |
| 002C32 | H. H. Fernandez [États-Unis] ; M. C. Lannon [États-Unis] ; J. H. Friedman [États-Unis] ; B. P. Abbott [États-Unis] | Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease |
| 002C54 | J. H. Friedman [États-Unis] ; S. A. Factor | Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease |
| 002D34 | H. H. Fernandez [États-Unis] ; J. H. Friedman [États-Unis] ; C. Jacques [États-Unis] ; M. Rosenfeld [États-Unis] | Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease |
| This area was generated with Dilib version V0.6.23. |  |